Preliminary study on efficacy and safety of pixantrone in relapsed/refractory aggressive B-cell lymphomas: multicenter, retrospective cohort study by Polish Lymphoma Research Group (PLRG).
- DOI
- 10.21037/cco-2026-1-0026
- Published
- 2026 Aug
- Container
- Chinese clinical oncology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/cco-2026-1-0026,
title = {Preliminary study on efficacy and safety of pixantrone in relapsed/refractory aggressive B-cell lymphomas: multicenter, retrospective cohort study by Polish Lymphoma Research Group (PLRG).},
author = {Witkowska M and Szmit S and Kołkowska-Leśniak A and Kuszczak B and Kasza R and Koclęga A and Bachanek-Mitura O and Wołowiec D},
year = {2026},
journal = {Chinese clinical oncology},
doi = {10.21037/cco-2026-1-0026},
url = {https://doi.org/10.21037/cco-2026-1-0026}
}RIS
TY - JOUR TI - Preliminary study on efficacy and safety of pixantrone in relapsed/refractory aggressive B-cell lymphomas: multicenter, retrospective cohort study by Polish Lymphoma Research Group (PLRG). AU - Witkowska M AU - Szmit S AU - Kołkowska-Leśniak A AU - Kuszczak B AU - Kasza R AU - Koclęga A AU - Bachanek-Mitura O AU - Wołowiec D PY - 2026 JO - Chinese clinical oncology DO - 10.21037/cco-2026-1-0026 UR - https://doi.org/10.21037/cco-2026-1-0026 ER -
APA
M, W., S, S., A, K., B, K., R, K., A, K., O, B., & D, W. (2026). Preliminary study on efficacy and safety of pixantrone in relapsed/refractory aggressive B-cell lymphomas: multicenter, retrospective cohort study by Polish Lymphoma Research Group (PLRG).. Chinese clinical oncology. https://doi.org/10.21037/cco-2026-1-0026
Source records
- pubmed · retrieved 2026-09-26T22:47:34.513Z
- europe-pmc · retrieved 2026-09-26T22:47:34.532Z